Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

APD-356 enters phase I trial for obesity

Feb. 26, 2004

Nastech's intranasal PYY3-36 spray tested in phase Ic study for obesity

Feb. 26, 2004

New lower dose Prempro available

Feb. 26, 2004

Enrollment extended in AIM study of I2S in Hunter syndrome

Feb. 25, 2004

BioMarin initiates PKU clinical program

Feb. 25, 2004

Researchers at Karo Bio and BMS present novel thyroid receptor modulators

Feb. 25, 2004

NO plays an important role in improving insulin action by pioglitazone

Feb. 25, 2004

Positive Life-Star and Health-Star phase III results due shortly

Feb. 25, 2004

Topical NO donor DS1 increases vaginal blood flow in rats

Feb. 25, 2004

NPC1L1 identified as a protein involved in intestinal cholesterol absorption and action of ezetimibe

Feb. 24, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 27, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
In the clinic for May 26, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage,...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...